Get in touch
© 2014-2024 Hospitality Medservice. All rights reserved.
Get in touch

BCG vaccine immunotherapy

I accept Terms and Conditions and agree to receive marketing letters that can be interesting for me.

Intravesical BCG vaccine immunotherapy is a highly effective treatment for malignant bladder tumors. The recurrence rate with Calmette-Guérin (BCG) immunization is reduced by up to 40%, significantly outperforming chemotherapy.

Although the BCG vaccine is primarily used to induce active immunity against tuberculosis, it also possesses anti-tumor activity.

Features of the procedure in global clinics

Intravesical therapy is an integral part of comprehensive treatment, widely applied in European hospitals following surgical intervention. It is recommended when bladder cancer has not spread beyond the mucosal lining.

Indications for BCG immunotherapy:

  • Non-invasive bladder cancer (carcinoma in situ)
  • Prevention of recurrence after TUR (transurethral resection)